FDAFDA · Food and drugs·Recall number D-0601-2021
Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) per carton, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA; Manufactured by: Mylan Institutional, Galway, Ireland. NDC: 67457-196-02
Published June 9, 2021 · Recall initiated: May 3, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- THIAMINE HYDROCHLORIDE
- Manufacturer
- Mylan Institutional LLC
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 200906, Exp. Date February 2022
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.